Skip to main content Skip to main menu
UF Health University of Florida
Department of Psychiatry College of Medicine
Call Today! 352.265.HELP (4357)
Gary L Kanter

Gary L Kanter, M.D.

Associate Professor

Department: MD-PSYCHIATRY
Business Phone: (352) 265-4357
Business Email: kanter@ufl.edu

About Gary L Kanter

After completion of his psychiatric residency, Dr. Kanter established his private practice of psychiatry in Gainesville, Florida in 1984. Dr. Kanter provided outpatient psychiatric services including psychodynamic psychotherapy, psychopharmacology, consultation and supervision for thirty-three years.   

In June 2016 he joined the University of Florida College of Medicine Department of Psychiatry with the focus on the education of the psychiatric residents and the articulation of psychotherapy and psychopharmacological skills within the outpatient clinical setting.

Accomplishments

Faculty Leadership Development Award
2018 · University of Florida, College of Medicine
Carlos E. Muniz, MD Mentor Award
2017 · Department of Psychiatry, University of Florida

Teaching Profile

Courses Taught
2018
MDT7840 Elect Top/Psychiatry

Board Certifications

  • Distinguished Life Fellow
    American Psychiatric Association
  • Psychiatry
    American Board of Psychiatry and Neurology

Clinical Profile

Specialties
  • Psychiatry
Areas of Interest
  • Anorexia
  • Attention deficit hyperactivity disorder
  • Binge eating disorder
  • Borderline personality disorder
  • Bulimia
  • Depression
  • Generalized anxiety disorder
  • Narcissistic personality disorder
  • Panic disorder
  • Persistent depressive disorder
  • Suicide and suicidal behavior
  • Transcranial Magnetic Stimulation (TMS)

Grants

Jun 2021 ACTIVE
A Multicenter, 48-week Open-Label Safety Study of Adjunctive Troriluzole in Subjects with Obsessive Compulsive Disorder
Role: Principal Investigator
Funding: COGNITIVE RESEARCH CORPORATION via BIOHAVEN PHARMACEUTICALS
Apr 2021 ACTIVE
A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder
Role: Principal Investigator
Funding: BIOHAVEN PHARMACEUTICALS
Feb 2018 – Feb 2023
A randomized, double-blind, placebo-controlled trial of adjunctive BHV-4157 in Obsessive Compulsive Disorder
Role: Principal Investigator
Funding: BIOHAVEN PHARMACEUTICALS

Education

Residency – Psychiatry
1983 · University of Rochester School of Medicine, Strong Memorial Hospital
Internship – Psychiatry
1980 · University of Rochester School of Medicine, Strong Memorial Hospital
Medical Degree
1979 · University of Rochester School of Medicine

Contact Details

Phones:
Business:
(352) 265-4357
Emails:
Business:
kanter@ufl.edu
Addresses:
Business Mailing:
PO Box 103424
 GAINESVILLE FL 32610
Business Street:
J256 JHMHC
 GAINESVILLE FL 32611